-

Publix Follows Guidance and Suspends Administration of Johnson & Johnson COVID-19 Vaccine

LAKELAND, Fla.--(BUSINESS WIRE)--Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

Customers can visit publix.com/covidvaccine to schedule an appointment for the Moderna COVID-19 vaccine, if currently available in their state.

The CDC and FDA have issued a joint media statement with additional information about the Johnson & Johnson COVID-19 vaccine. According to the CDC and FDA, while a rare side effect, individuals who have received the Johnson & Johnson COVID-19 vaccine should contact their health care provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination.

Publix, the largest employee-owned company in the U.S. with more than 225,000 associates, currently operates 1,270 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia. For 24 consecutive years, the company has been recognized by Fortune as a great place to work. In addition, Publix’s dedication to superior quality and customer service is recognized among the top in the grocery business. For more information, visit the company’s website, corporate.publix.com.

Contacts

Maria Brous
(863) 680-5339

Industry:

Publix

Release Versions
English

Contacts

Maria Brous
(863) 680-5339

More News From Publix

Publix Reports Second Quarter 2026 Results and Stock Price

LAKELAND, Fla.--(BUSINESS WIRE)--Publix’s sales for the three months ended June 27, 2026 were $15.7 billion, a 1% increase from $15.6 billion in 2025. Publix’s sales for the six months ended June 27, 2026 were $31.9 billion, a 1.5% increase from $31.4 billion in 2025. The increase in sales for the three and six months ended June 27, 2026 compared to the three and six months ended June 28, 2025 was lower due to the impact of the Medicare maximum fair price (MFP) change effective January 1, 2026...

Publix Pharmacy Participates in the Medicare GLP-1 Bridge Program

LAKELAND, Fla.--(BUSINESS WIRE)--Eligible Medicare Plan D beneficiaries can have qualifying GLP-1 prescriptions filled at a Publix Pharmacy as part of the Medicare GLP-1 Bridge program. On July 1, 2026, the Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge program, a new initiative designed to expand access to innovative GLP-1 drugs for weight management. The program will remain available through Dec. 31, 2027. Covered Prescriptions The GLP-1 drugs currently availa...

Publix Recalls All Lots of GreenWise Organic Frozen Blueberries and Whole Mixed Berries Due to Potential E. coli O145 Contamination

LAKELAND, Fla.--(BUSINESS WIRE)--Publix is recalling all lots of GreenWise Organic Whole Blueberries and Whole Mixed Berries because they may be contaminated with Escherichia coli O145:H28 (E. coli O145). E. coli O145 is a Shiga toxin-producing E. coli (STEC) that can cause illness characterized by severe stomach cramps, diarrhea (which may be bloody) and vomiting. While most healthy individuals recover within a week, some infections may result in a serious complication known as hemolytic uremi...
Back to Newsroom